Cogentix Medical, Inc. (NASDAQ:CGNT) is set to issue its quarterly earnings data after the market closes on Monday, November 6th. Analysts expect the company to announce earnings of ($0.01) per share for the quarter.

Shares of Cogentix Medical, Inc. (NASDAQ:CGNT) opened at $2.92 on Friday. Cogentix Medical, Inc. has a twelve month low of $1.52 and a twelve month high of $3.26.

CGNT has been the subject of several research analyst reports. Zacks Investment Research raised shares of Cogentix Medical from a “hold” rating to a “buy” rating and set a $2.50 target price for the company in a report on Friday, August 4th. JMP Securities initiated coverage on shares of Cogentix Medical in a report on Friday, October 6th. They set an “outperform” rating and a $5.00 target price for the company.

An institutional investor recently raised its position in Cogentix Medical stock. Northern Trust Corp boosted its holdings in Cogentix Medical, Inc. (NASDAQ:CGNT) by 0.4% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 73,926 shares of the medical device company’s stock after purchasing an additional 326 shares during the quarter. Northern Trust Corp owned 0.12% of Cogentix Medical worth $129,000 at the end of the most recent reporting period. Institutional investors own 12.64% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Cogentix Medical, Inc. (CGNT) Set to Announce Quarterly Earnings on Monday” was reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at

Cogentix Medical Company Profile

Cogentix Medical, Inc is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB).

Earnings History for Cogentix Medical (NASDAQ:CGNT)

Receive News & Ratings for Cogentix Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cogentix Medical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.